Berkshire Asset Management LLC Immunity Bio, Inc. Transaction History

Berkshire Asset Management LLC

  • $1.89 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.68 - $6.14 $40,200 - $92,100
-15,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$5.67 - $10.18 $28,350 - $50,900
-5,000 Reduced 25.0%
15,000 $91,000
Q2 2021

Aug 16, 2021
BUY
$13.41 - $22.4 $67,050 - $112,000
5,000 Added 33.33%
20,000 $286,000
Q1 2021

May 17, 2021
BUY
$12.83 - $42.25 $192,450 - $633,750
15,000 New
15,000 $356,000

Others Institutions Holding IBRX

# of Institutions
191
Shares Held
66.7M
Call Options Held
2.27M
Put Options Held
3.23M
View Full List

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.47B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Berkshire Asset Management LLC Portfolio

Follow Berkshire Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email